The journal Science has chosen the HPTN 052 clinical trial, an international HIV prevention trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, as the 2011 Breakthrough of the Year. The study found that if HIV-infected heterosexual individuals begin taking antiretroviral medicines when their immune systems are relatively healthy as opposed to delaying therapy until the disease has advanced, they are 96 percent less likely to transmit the virus to their uninfected partners. Findings from the trial, first announced in May, were published in the New England Journal of Medicine in August.

Medicare outpatient claims for 2008 are showing that thousands of Medicare patients received unnecessary double CT scans that year. The practice not only costs the Medicare program millions of dollars, but exposes patients to potentially dangerous doses of radiation.

A trial that had originally been planned to run until 2015, testing whether treating an HIV-infected person with antiretroviral drugs could prevent that person from passing the disease along to his partner, stopped on thursday. Because it was so successful.

A pill that gives men with advanced prostate cancer an extra four months of life has come a step closer to being approved for use in Britain.

Scientists, already adept at using magnets to screw with the brain’s ability to generate speech, are now sending direct current into people’s brain matter to help them master video games.

You know the UV-ink rubber stamps at night clubs? Well, a novel silver nanotech variant of the idea could actually help heal your skin wounds more quickly.
Three new oral blood-thinning drugs nearing approval by the Food and...
the truth about me is that I genuinely believe that nothing is as bad as it seems. the truth about me is that I feel and think things I’m...
Temporarily together (via raw_reflex)
I like the cool “http” board. Looks like an internet suite!